Portal de Periódicos da CAPES

The Clinical Usefulness of Prostate Specific Antigen: Update 1994

1994; Lippincott Williams & Wilkins; Volume: 152; Issue: 5 Part 1 Linguagem: Inglês

10.1016/s0022-5347(17)32422-9

1527-3792

Alan W. Partin, Joseph E. Oesterling,

Urologic and reproductive health conditions

No AccessJournal of UrologyReview Article1 Nov 1994The Clinical Usefulness of Prostate Specific Antigen: Update 1994 Alan W. Partin and Joseph E. Oesterling Alan W. PartinAlan W. Partin and Joseph E. OesterlingJoseph E. Oesterling View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)32422-9AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail © 1994 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byFarolfi A, Gafita A, Calais J, Eiber M, Afshar-Oromieh A, Spohn F, Barbato F, Weber M, Ilhan H, Cervati V, Wetter A, Hadaschik B, Briganti A, Walz J, Pianori D, Fanti S, Haberkorn U, Herrmann K and Fendler W (2019) 68Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyJournal of Urology, VOL. 202, NO. 6, (1174-1181), Online publication date: 1-Dec-2019.DJAVAN B, WALDERT M, ZLOTTA A, DOBRONSKI P, SEITZ C, REMZI M, BORKOWSKI A, SCHULMAN C and MARBERGER M (2018) SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDYJournal of Urology, VOL. 166, NO. 3, (856-860), Online publication date: 1-Sep-2001.STEINER M and GINGRICH J (2018) GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?Journal of Urology, VOL. 164, NO. 4, (1121-1136), Online publication date: 1-Oct-2000.HAESE A, BECKER C, NOLDUS J, GRAEFEN M, HULAND E, HULAND H and LILJA H (2018) HUMAN GLANDULAR KALLIKREIN 2: A POTENTIAL SERUM MARKER FOR PREDICTING THE ORGAN CONFINED VERSUS NONORGAN CONFINED GROWTH OF PROSTATE CANCERJournal of Urology, VOL. 163, NO. 5, (1491-1497), Online publication date: 1-May-2000.DJAVAN B, ZLOTTA A, REMZI M, GHAWIDEL K, BASHARKHAH A, SCHULMAN C and MARBERGER M (2018) OPTIMAL PREDICTORS OF PROSTATE CANCER ON REPEAT PROSTATE BIOPSY: A PROSPECTIVE STUDY OF 1,051 MENJournal of Urology, VOL. 163, NO. 4, (1144-1149), Online publication date: 1-Apr-2000.EASTHAM J and KATTAN M (2018) DISEASE RECURRENCE IN BLACK AND WHITE MEN UNDERGOING RADICAL PROSTATECTOMY FOR CLINICAL STAGE T1-T2 PROSTATE CANCERJournal of Urology, VOL. 163, NO. 1, (143-145), Online publication date: 1-Jan-2000.ETZIONI R, CHA R and COWEN M (2018) SERIAL PROSTATE SPECIFIC ANTIGEN SCREENING FOR PROSTATE CANCER: A COMPUTER MODEL EVALUATES COMPETING STRATEGIESJournal of Urology, VOL. 162, NO. 3 Part 1, (741-748), Online publication date: 1-Sep-1999.POLASCIK T, OESTERLING J and PARTIN A (2018) PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, VOL. 162, NO. 2, (293-306), Online publication date: 1-Aug-1999.CLEMENTS J, ROHDE P, ALLEN V, HYLAND V, SAMARATUNGA M, TILLEY W, LAVIN M and GARDINER R (2018) MOLECULAR DETECTION OF PROSTATE CELLS IN EJACULATE AND URETHRAL WASHINGS IN MEN WITH SUSPECTED PROSTATE CANCERJournal of Urology, VOL. 161, NO. 4, (1337-1343), Online publication date: 1-Apr-1999.GAO C, DEAN R, PINTO A, MOONEYHAN R, CONNELLY R, McLEOD D, SRIVASTAVA S and MOUL J (2018) DETECTION OF CIRCULATING PROSTATE SPECIFIC ANTIGEN EXPRESSING PROSTATIC CELLS IN THE BONE MARROW OF RADICAL PROSTATECTOMY PATIENTS BY SENSITIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTIONJournal of Urology, VOL. 161, NO. 4, (1070-1076), Online publication date: 1-Apr-1999.CHOI B, STECKEL J, DENOTO G, VAUGHAN E and SCHLEGEL P (2018) PREPERITONEAL PROSTHETIC MESH HERNIOPLASTY DURING RADICAL RETROPUBIC PROSTATECTOMYJournal of Urology, VOL. 161, NO. 3, (840-843), Online publication date: 1-Mar-1999.CHERRY J, MORDENTE J, CHAPMAN J, CHOUDHURY M, TAZAKI H, MALLOUH C and KONNO S (2018) ANALYSIS OF CATHEPSIN D FORMS AND THEIR CLINICAL IMPLICATIONS IN HUMAN PROSTATE CANCERJournal of Urology, VOL. 160, NO. 6 Part 1, (2223-2228), Online publication date: 1-Dec-1998.ZLOTTA A, DJAVAN B, PETEIN M, SUSANI M, MARBERGER M and SCHULMAN C (2018) PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER IN PATIENTS WITH SERUM PROSTATE SPECIFIC ANTIGEN LESS THAN 10 NG./ML.Journal of Urology, VOL. 160, NO. 6 Part 1, (2089-2095), Online publication date: 1-Dec-1998.BETTENCOURT M, BAUER J, SESTERHENN I, CONNELLY R and MOUL J (2018) CD34 IMMUNOHISTOCHEMICAL ASSESSMENT OF ANGIOGENESIS AS A PROGNOSTIC MARKER FOR PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMYJournal of Urology, VOL. 160, NO. 2, (459-465), Online publication date: 1-Aug-1998.DJAVAN B, ZLOTTA A, BYTTEBIER G, SHARIAT S, OMAR M, SCHULMAN C and MARBERGER M (2018) PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR EARLY DETECTION OF PROSTATE CANCERJournal of Urology, VOL. 160, NO. 2, (411-418), Online publication date: 1-Aug-1998.GREENE G, PISTERS L, SCOTT S and VON ESCHENBACH A (2018) PREDICTIVE VALUE OF PROSTATE SPECIFIC ANTIGEN NADIR AFTER SALVAGE CRYOTHERAPYJournal of Urology, VOL. 160, NO. 1, (86-90), Online publication date: 1-Jul-1998.AARNINK R, BEERLAGE H, DE LA ROSETTE J, DEBRUYNE F and WIJKSTRA H (2018) TRANSRECTAL ULTRASOUND OF THE PROSTATE: INNOVATIONS AND FUTURE APPLICATIONSJournal of Urology, VOL. 159, NO. 5, (1568-1579), Online publication date: 1-May-1998.PANNEK J, RITTENHOUSE H, CHAN D, EPSTEIN J, WALSH P and PARTIN A (2018) THE USE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN FOR STAGING CLINICALLY LOCALIZED PROSTATE CANCERJournal of Urology, VOL. 159, NO. 4, (1238-1242), Online publication date: 1-Apr-1998.MOUL J, CONNELLY R, PERAHIA B and MCLEOD D (2018) THE CONTEMPORARY VALUE OF PRETREATMENT PROSTATIC ACID PHOSPHATASE TO PREDICT PATHOLOGICAL STAGE AND RECURRENCE IN RADICAL PROSTATECTOMY CASESJournal of Urology, VOL. 159, NO. 3, (935-940), Online publication date: 1-Mar-1998.BAUER J, CONNELLY R, SETERHENN I, DEAUSEN J, SRIVASTAVA S, MCLEOD D and MOUL J (2018) BIOSTATISTICAL MODELING USING TRADITIONAL PREOPERATIVE AND PATHOLOGICAL PROGNOSTIC VARIABLES IN THE SELECTION OF MEN AT HIGH RISK FOR DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCERJournal of Urology, VOL. 159, NO. 3, (929-933), Online publication date: 1-Mar-1998.Cadeddu J, Partin A, DeWeese T and Walsh P (2018) LONG-TERM RESULTS OF RADIATION THERAPY FOR PROSTATE CANCER RECURRENCE FOLLOWING RADICAL PROSTATECTOMYJournal of Urology, VOL. 159, NO. 1, (173-178), Online publication date: 1-Jan-1998.O'Dowd G, Veltri R, Orozco R, Miller M and Oesterling J (2018) Update on the Appropriate Staging Evaluation for Newly Diagnosed Prostate CancerJournal of Urology, VOL. 158, NO. 3, (687-698), Online publication date: 1-Sep-1997.Fleshner N, O'Sullivan M and Fair W (2018) Prevalence and Predictors of a Positive Repeat Transrectal Ultrasound Guided Needle Biopsy of the ProstateJournal of Urology, VOL. 158, NO. 2, (505-509), Online publication date: 1-Aug-1997.Ornstein D, Smith D, Rao G, Basler J, Ratliff T and Catalona W (2018) Biological Variation of Total, Free and Percent Free Serum Prostate Specific Antigen Levels in Screening VolunteersJournal of Urology, VOL. 157, NO. 6, (2179-2182), Online publication date: 1-Jun-1997.Harris C, Dalkin B, Martin E, Marx P and Ahmann F (2018) Prospective Longitudinal Evaluation of Men With Initial Prostate Specific Antigen Levels of 4.0 Ng./Ml. or LessJournal of Urology, VOL. 157, NO. 5, (1740-1743), Online publication date: 1-May-1997.Witherspoon L and Lapeyrolerie T (2018) Sensitive Prostate Specific Antigen Measurements Identify Men With Long Disease-Free Intervals and Differentiate Aggressive from Indolent Cancer Recurrences within 2 Years After Radical ProstatectomyJournal of Urology, VOL. 157, NO. 4, (1322-1328), Online publication date: 1-Apr-1997.Zlotta A, Djavan B, Marberger M and Schulman C (2018) Prostate Specific Antigen Density of the Transition Zone: A New Effective Parameter for Prostate Cancer PredictionJournal of Urology, VOL. 157, NO. 4, (1315-1321), Online publication date: 1-Apr-1997.Breul J, Pickl U and Schaff J (2018) Extraprostatic Production of Prostate Specific Antigen is Under Hormonal ControlJournal of Urology, VOL. 157, NO. 1, (212-213), Online publication date: 1-Jan-1997.Terris M, Pham T, Issa M and Kabalin J (2018) Routine Transition Zone and Seminal Vesicle Biopsies in All Patients Undergoing Transrectal Ultrasound Guided Prostate Biopsies are Not IndicatedJournal of Urology, VOL. 157, NO. 1, (204-206), Online publication date: 1-Jan-1997.Colombo T, Zigeuner R, Altziebler S, Pummer K, Stettner H and Hubmer G (2018) Effect of Extracorporeal Shock Wave Lithotripsy on Prostate Specific AntigenJournal of Urology, VOL. 156, NO. 5, (1682-1684), Online publication date: 1-Nov-1996.Bauer J, Sesterhenn I, Mostofi F, McLeod D, Srivastava S and Moul J (2018) Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate CancerJournal of Urology, VOL. 156, NO. 4, (1511-1516), Online publication date: 1-Oct-1996.Bettencourt M, Bauer J, Sesterhenn I, Mostofi F, McLeod D and Moul J (2018) Ki-67 Expression is a Prognostic Marker of Prostate Cancer Recurrence after Radical ProstatectomyJournal of Urology, VOL. 156, NO. 3, (1064-1068), Online publication date: 1-Sep-1996.Lee W, Hanlon A and Hanks G (2018) Prostate specific antigen nadir following external beam radiation therapy for clinically localized prostate Cancer: The relationship between nadir level and disease-free survivalJournal of Urology, VOL. 156, NO. 2, (450-453), Online publication date: 1-Aug-1996.Pelger R, Lycklama G, Nijeholt A, Zwinderman A, Papapoulos S and Hamdy N (2018) The Flare in Serum Alkaline Phosphatase Activity After Orchiectomy: A Valuable Negative Prognostic Index for Progression-Free Survival in Prostatic CarcinomaJournal of Urology, VOL. 156, NO. 1, (122-126), Online publication date: 1-Jul-1996.Moul J, Douglas T, McCarthy W and McLeod D (2018) Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care SettingJournal of Urology, VOL. 155, NO. 5, (1667-1673), Online publication date: 1-May-1996.Oesterling J, Tekchandani A, Martin S, Bergstralh E, Reichstein E, Diamandis E, Yemoto C and Stamey T (2018) The Periurethral Glands do not Significantly Influence the Serum Prostate Specific Antigen ConcentrationJournal of Urology, VOL. 155, NO. 5, (1658-1660), Online publication date: 1-May-1996.Lorente J, Morote J, Raventos C, Encabo G and Valenzuela H (2018) Clinical Efficacy of Bone Alkaline Phosphatase and Prostate Specific Antigen in the Diagnosis of Bone Metastasis in Prostate CancerJournal of Urology, VOL. 155, NO. 4, (1348-1351), Online publication date: 1-Apr-1996.Partin A, Criley S, Subong E, Zincke H, Walsh P and Oesterling J (2018) Standard Versus Age-Specific Prostate Specific Antigen Reference Ranges Among Men With Clinically Localized Prostate Cancer: A Pathological AnalysisJournal of Urology, VOL. 155, NO. 4, (1336-1339), Online publication date: 1-Apr-1996.Moul J, Maygarden S, Ware J, Mohler J, Maher P, Schenkman N and Ho C (2018) Cathepsin D and Epidermal Growth Factor Receptor Immunohistochemistry does not Predict Recurrence of Prostate Cancer in Patients Undergoing Radical ProstatectomyJournal of Urology, VOL. 155, NO. 3, (982-985), Online publication date: 1-Mar-1996.Partin A (2018) Editorial: Prostate Cancer-Educating Ourselves and Our Nonurological ColleaguesJournal of Urology, VOL. 155, NO. 2, (610-611), Online publication date: 1-Feb-1996.Partin A and Oesterling J (2018) In Reply: Re: The Clinical Usefulness of Prostate Specific Antigen: Update 1994Journal of Urology, VOL. 155, NO. 1, (295-295), Online publication date: 1-Jan-1996.Sheinfeld J and Fleshner N (2018) Editorial: Prostate CancerJournal of Urology, VOL. 154, NO. 5, (1806-1807), Online publication date: 1-Nov-1995.Fleshner N and Trachtenberg J (2018) Combination Finasteride and Flutamide in Advanced Carcinoma of the Prostate: Effective Therapy with Minimal Side EffectsJournal of Urology, VOL. 154, NO. 5, (1642-1646), Online publication date: 1-Nov-1995. Volume 152Issue 5 Part 1November 1994Page: 1358-1368 Advertisement Copyright & Permissions© 1994 by The American Urological Association Education and Research, Inc.Keywordsprostatic neoplasmstumor markersbiologicalantigensMetricsAuthor Information Alan W. Partin More articles by this author Joseph E. Oesterling More articles by this author Expand All Advertisement PDF downloadLoading ...